Like its English-language predecessor, which launched in 2016, this Spanish-language patient community from MyHealthTeam is ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

Industry Veterans Appointed to Drive Strategic Vision of the Specialized Investment FundBOSTON, Oct. 16, 2024 (GLOBE NEWSWIRE) -- NYBC Ventures LLC (“NYBC Ventures”), a specialized fund focused on ...

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected ...

Despite a 7% YTD gain, IBB ETF has underperformed the S&P 500, which is up 21%, and shows negative alpha. Read more on IBB ...

Who is Nirmala Bandrapalli? Nirmal Bandrapalli, a mother of three and a 20-year Burlingame resident, is running for a seat on ...

The outcome of the 2024 U.S. presidential election is poised to affect the biotechnology sector, as both major parties present policy proposals that could reshape drug pricing, regulation, and ...

Initiated Phase 1b dose expansion of NX-5948 in chronic lymphocytic leukemia patient population with Fast Track Designation from the FDAInitiated ...

In a year that has seen an approval and a raft of readouts for metabolic dysfunction-associated steatohepatitis (MASH), ...

Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.